Partner Emily Cowley Leongini was quoted on Sarepta Therapeutics’ decision to pause sales of its Duchenne muscular dystrophy gene therapy Elevidys (delandistrogene moxeparvovec) following a request from the US Food and Drug Administration (FDA).
Partner Ehsun Forghany was interviewed by Law360 about the US Patent and Trademark Office’s (USPTO) upcoming launch of DesignVision — an artificial intelligence (AI)-powered tool for conducting image-based prior art searches for design patents.
D. Jacques Smith, Michelle J. Shapiro, Rebekkah R.N. Stoeckler, Stephanie Trunk, Nadia Patel, Pascal Naples
The government has announced a renewed and expanded focus on False Claims Act enforcement, doubling down on traditional healthcare priorities like kickbacks and drug pricing while signaling increased scrutiny of electronic health records manipulation, a shift that could expose data vendors and other nontraditional healthcare entities to scrutiny from the US Department of Justice and the US Department of Health and Human Services.
Investigations Practice Group Leader D. Jacques Smith and Health Care Industry Co-Leader Nadia Patel were quoted on the recent increase in health care enforcement actions under the False Claims Act (FCA), as it remains a top priority for the US Department of Justice (DOJ).
In Law360’s 2025 midyear report, Partner Danielle Bulger was quoted on recent, pivotal copyright rulings by US district courts, including regarding implications of the affirmative defense of fair use in the context of AI model training, and copyright litigation strategy.
FDA Practice Group Leader Karen Carr was featured on The International Fresh Produce Association’s (IFPA) podcast, Fresh Takes on Tech, in its recent episode “Science and Policy: The Battle Shaping Ag Biotechnology.”
Partner J. Michael Showalter discussed the growing impact of artificial intelligence (AI)- driven data centers on energy demand and emissions.
Partner Ehsun Forghany was interviewed by Law360 on the rise of patent case filings, particularly in the Eastern District of Texas, which, after receiving 1,069 new patent complaints in 2024, surpassed the Western District of Texas as the most popular venue for patent litigation.
Gayland Hethcoat was quoted on a federal judge’s order to remove the confidentiality designation from hundreds of hours of recordings of presentations and panel discussions that were produced in discovery by the World Professional Association for Transgender Health (WPATH), which is often cited by expert witnesses in cases regarding gender-affirming care.
Customs & Import Compliance Practice Group Leader Angela Santos was quoted on the Trump Administration’s alternative pathways for imposing tariffs. After the Court of International Trade and District Court for the District of Columbia put a halt to Trump’s tariffs, Administration officials say that the president is considering using other tools at his disposal to advance his trade policies.
Partner Antonio Rivera was quoted on the federal court decision that President Trump exceeded his authority when he used the 1977 International Emergency Economic Powers Act (IEEPA) to impose worldwide tariffs by declaring a national emergency based on trade deficits.
Partner Ehsun Forghany was quoted by CosmeticsDesign USA on how industry stakeholders should revisit and revise their intellectual property (IP) strategies after the May 2 closure of the de minimis loophole.
Partner J. Michael Showalter was quoted on the Trump Administration’s lawsuits testing the judiciary’s stance on federal interests in state affairs, particularly concerning state-led climate change initiatives.
Chairman Anthony Lupo and Consumer Products Group Co-Leader Michelle Mancino Marsh were quoted on how attorneys play a pivotal role behind the scenes at the Met Gala, one of the world’s premier fashion events.
Partner Douglas Grimm was quoted on the US Supreme Court’s ruling Loper Bright Enterprises v. Raimondo, marking one year since the landmark decision that ended judicial deference to agency rulemaking.
Partner Jay Halpern was quoted on how restaurants and suppliers are navigating the impact of tariffs on essential supplies.
Customs & Import Compliance Practice Leader Angela Santos was quoted on how importers are strategizing to lessen their liability under the Trump Administration’s tariffs.
Gayland Hethcoat was quoted on the potential for increased data privacy litigation targeting health plans, with the Blue Shield case possibly sparking a “broader wave” of lawsuits.
Partner Emily Cowley Leongini was quoted on the federal court decision regarding the oversight of laboratory-developed tests by the US Food and Drug Administration.
In a recent discussion at SupplySide Connect in Secaucus, Associate Mario Torrico addressed the impact of tariffs on global supply chains.
Consumer Products Co-Leader Katia Asche discussed California’s Assembly Bill 728, which seeks to ban the sale of over-the-counter skincare products containing retinol and alpha hydroxy acid (AHA) to minors under the age of 18.
The Consulate General of Finland featured Partner Jon Jurva, Finnish Honorary Consul in Chicago, highlighting his contributions to supporting diplomatic and cultural ties between Finland and the United States.
Partner David Greenberg was quoted on a series of patient lawsuits challenging the alleged use of artificial intelligence (AI) and algorithms by health insurers, commenting on the potential hazards of insurers using the technology.
Partner David Dubrow was quoted on the use of artificial intelligence in fraud in response to the US Securities and Exchange Commission’s (SEC) complaint against three individuals who allegedly use fake documents to defraud investors in municipal bonds.
James Kim was quoted on how the Trump Administration’s new 25% tariffs on cars and auto parts are prompting automakers and suppliers to reassess the North American automotive supply chain.